Jan-Peter Böhme

Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved.

ASSA ABLOY Global Solutions AB develops, markets, and sells embedded systems and software for communication between mobile phones and bluetooth devices. The company was founded by Mats Almeby, Johan Horberg, and Jonas Runesson on September, 7, 2004 and is headquartered in Halmstad, Sweden.

Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden.

LYYN AB engages in the development and provision of visibility enhancing technology. Its technology enables to enhance visibility in real-time in fog, dust, lowlight, snow, smoke, and subsea. The firm's products include LYYN Hawk Portable, LYYN Hawk Board, LYYN Hawk System, and LYYN Griffin. The company was founded by Anders Olof Holm and Olle Holm in 2003 and is headquartered in Lund, Sweden.